Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 06-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -68,288 | -29,219 | -17,839 | -22,313 |
| Depreciation Amortization | 2,154 | 981 | 1,943 | 2,053 |
| Other Working Capital | 3,640 | -2,560 | -7,375 | 14,176 |
| Other Operating Activity | 17,854 | 13,604 | 2,695 | 3,319 |
| Operating Cash Flow | $-44,640 | $-17,194 | $-20,576 | $-2,765 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,956 | -337 | -252 | -48 |
| Other Investing Activity | -1,250 | -1,250 | 0 | 0 |
| Investing Cash Flow | $-3,206 | $-1,587 | $-252 | $-48 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 127,427 | 95,488 | 95,678 | 0 |
| Financing Cash Flow | $127,427 | $95,488 | $95,678 | $0 |
| Exchange Rate Effect | 47 | 47 | 165 | -38 |
| Beginning Cash Position | 91,278 | 91,278 | 16,263 | 19,114 |
| End Cash Position | 170,906 | 168,032 | 91,278 | 16,263 |
| Net Cash Flow | $79,628 | $76,754 | $75,015 | $-2,851 |
| Free Cash Flow | ||||
| Operating Cash Flow | -44,640 | -17,194 | -20,576 | -2,765 |
| Free Cash Flow | -44,640 | -17,194 | -20,576 | -2,765 |